1. Home
  2. HUMAW vs LFMDP Comparison

HUMAW vs LFMDP Comparison

Compare HUMAW & LFMDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Humacyte Inc. Warrant

HUMAW

Humacyte Inc. Warrant

N/A

Current Price

$0.12

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Logo LifeMD Inc.

LFMDP

LifeMD Inc.

N/A

Current Price

$22.28

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HUMAW
LFMDP
Founded
2004
N/A
Country
United States
United States
Employees
220
336
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HUMAW
LFMDP
Price
$0.12
$22.28
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
14.2K
N/A
Earning Date
03-21-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.18
N/A
52 Week High
$1.34
N/A

Technical Indicators

Market Signals
Indicator
HUMAW
LFMDP
Relative Strength Index (RSI) 49.47 53.21
Support Level $0.10 $21.90
Resistance Level $0.15 $23.24
Average True Range (ATR) 0.03 0.36
MACD 0.01 0.12
Stochastic Oscillator 62.98 66.97

Price Performance

Historical Comparison
HUMAW
LFMDP

About HUMAW Humacyte Inc. Warrant

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

About LFMDP LifeMD Inc.

LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.

Share on Social Networks: